Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial

A. Pudipeddi; H. Lin; S. Paramsothy; V. Kariyawasam; R. Paramsothy; S. Ghaly; C. Haifer; Y. K. An; J. Begun; S. Connor; C. Corte; M. Ward; P. De Cruz; C. Fung; D. Redmond; W. Chan; F. Mourad; M. Kermeen; R. Leong

doi:10.1093/ecco-jcc/jjae190.0928

Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial

A. Pudipeddi, H. Lin, S. Paramsothy, V. Kariyawasam, R. Paramsothy, S. Ghaly, C. Haifer, Y. K. An, J. Begun, S. Connor, C. Corte, M. Ward, P. De Cruz, C. Fung, D. Redmond, W. Chan, F. Mourad, M. Kermeen, R. Leong

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	i1453-i1454
Number of pages	2
Journal	Journal of Crohn's and Colitis
Volume	19
Issue number	Supplement 1
DOIs	https://doi.org/10.1093/ecco-jcc/jjae190.0928
Publication status	Published - 22 Jan 2025
Event	20th Congress of the European Crohn's and Colitis Organisation (ECCO) - Berlin, Germany Duration: 19 Feb 2025 → 22 Feb 2025

Access to Document

10.1093/ecco-jcc/jjae190.0928

Cite this

Pudipeddi, A., Lin, H., Paramsothy, S., Kariyawasam, V., Paramsothy, R., Ghaly, S., Haifer, C., An, Y. K., Begun, J., Connor, S., Corte, C., Ward, M., De Cruz, P., Fung, C., Redmond, D., Chan, W., Mourad, F., Kermeen, M., & Leong, R. (2025). Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial. Journal of Crohn's and Colitis, 19(Supplement 1), i1453-i1454. https://doi.org/10.1093/ecco-jcc/jjae190.0928

@article{9538e79fc8fe4baeabf34e7ed6e55635,

title = "Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial",

author = "A. Pudipeddi and H. Lin and S. Paramsothy and V. Kariyawasam and R. Paramsothy and S. Ghaly and C. Haifer and An, {Y. K.} and J. Begun and S. Connor and C. Corte and M. Ward and {De Cruz}, P. and C. Fung and D. Redmond and W. Chan and F. Mourad and M. Kermeen and R. Leong",

year = "2025",

month = jan,

day = "22",

doi = "10.1093/ecco-jcc/jjae190.0928",

language = "English",

volume = "19",

pages = "i1453--i1454",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "Supplement 1",

note = "20th Congress of the European Crohn's and Colitis Organisation (ECCO) ; Conference date: 19-02-2025 Through 22-02-2025",

}

Pudipeddi, A, Lin, H, Paramsothy, S, Kariyawasam, V, Paramsothy, R, Ghaly, S, Haifer, C, An, YK, Begun, J, Connor, S, Corte, C, Ward, M, De Cruz, P, Fung, C, Redmond, D, Chan, W, Mourad, F, Kermeen, M & Leong, R 2025, 'Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, vol. 19, no. Supplement 1, pp. i1453-i1454. https://doi.org/10.1093/ecco-jcc/jjae190.0928

Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial. / Pudipeddi, A.; Lin, H.; Paramsothy, S. et al.
In: Journal of Crohn's and Colitis, Vol. 19, No. Supplement 1, 22.01.2025, p. i1453-i1454.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis

T2 - 20th Congress of the European Crohn's and Colitis Organisation (ECCO)

AU - Pudipeddi, A.

AU - Lin, H.

AU - Paramsothy, S.

AU - Kariyawasam, V.

AU - Paramsothy, R.

AU - Ghaly, S.

AU - Haifer, C.

AU - An, Y. K.

AU - Begun, J.

AU - Connor, S.

AU - Corte, C.

AU - Ward, M.

AU - De Cruz, P.

AU - Fung, C.

AU - Redmond, D.

AU - Chan, W.

AU - Mourad, F.

AU - Kermeen, M.

AU - Leong, R.

PY - 2025/1/22

Y1 - 2025/1/22

U2 - 10.1093/ecco-jcc/jjae190.0928

DO - 10.1093/ecco-jcc/jjae190.0928

M3 - Meeting abstract

SN - 1873-9946

VL - 19

SP - i1453-i1454

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - Supplement 1

Y2 - 19 February 2025 through 22 February 2025

ER -

Pudipeddi A, Lin H, Paramsothy S, Kariyawasam V, Paramsothy R, Ghaly S et al. Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial. Journal of Crohn's and Colitis. 2025 Jan 22;19(Supplement 1):i1453-i1454. doi: 10.1093/ecco-jcc/jjae190.0928